Studies with macrophage-specific Lgr4 knockout mice (Mac-L4KO) have shown improved cardiac function and a modest reduction in infarct size, suggesting that targeting macrophage Lgr4 could be a potential therapeutic strategy for myocardial infarction (Huang et al., 2020). Here, LGR4 is linked to myocardial infarction.